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Abstract
Background: During the development of the nervous system, neural progenitor cells can either stay in
the pool of proliferating undifferentiated cells or exit the cell cycle and differentiate. Two main factors will
determine the fate of a neural progenitor cell: its position within the neuroepithelium and the time at
which the cell initiates differentiation. In this paper we investigated the importance of the timing of cell
cycle exit on cell-fate decision by forcing neural progenitors to cycle and studying the consequences on
specification and differentiation programs.
Results: As a model, we chose the spinal progenitors of motor neurons (pMNs), which switch cell-fate
from motor neurons to oligodendrocytes with time. To keep pMNs in the cell cycle, we forced the
expression of G1-phase regulators, the D-type cyclins. We observed that keeping neural progenitor cells
cycling is not sufficient to retain them in the progenitor domain (ventricular zone); transgenic cells instead
migrate to the differentiating field (mantle zone) regardless of cell cycle exit. Cycling cells located in the
mantle zone do not retain markers of neural progenitor cells such as Sox2 or Olig2 but upregulate
transcription factors involved in motor neuron specification, including MNR2 and Islet1/2. These cycling
cells also progress through neuronal differentiation to axonal extension. We also observed mitotic cells
displaying all the features of differentiating motor neurons, including axonal projection via the ventral root.
However, the rapid decrease observed in the proliferation rate of the transgenic motor neuron population
suggests that they undergo only a limited number of divisions. Finally, quantification of the incidence of the
phenotype in young and more mature neuroepithelium has allowed us to propose that once the
transcriptional program assigning neural progenitor cells to a subtype of neurons is set up, transgenic cells
progress in their program of differentiation regardless of cell cycle exit.
Conclusion: Our findings indicate that maintaining neural progenitor cells in proliferation is insufficient
to prevent differentiation or alter cell-fate choice. Furthermore, our results indicate that the programs of
neuronal specification and differentiation are controlled independently of cell cycle exit.
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Background
Embryonic neural stem cells can either proliferate, thereby
maintaining a pool of undifferentiated neural progenitor
cells, or differentiate into neurons or macroglial cells. In
the developing nervous system two principal factors deter-
mine the fate of the differentiating neurons or glia: the
position of the neural progenitor cell within the neuroep-
ithelium and the timing of initiation of its differentiation.
In the developing spinal cord, the ventricular zone con-
tains neural progenitor cells that are subdivided into
groups destined for distinct neuronal differentiation [1].
At early developmental stages, the ventral neural progeni-
tor cells, termed progenitors of motor neurons (pMNs),
can produce motor neurons, while at later stages they dif-
ferentiate into oligodendrocytes. The pMNs express a
unique combination of homeodomain transcription fac-
tors, leading to the upregulation of the basic helix-loop-
helix (bHLH) transcription factor Olig2 [2-6]. Olig2 occu-
pies a key nodal point in the pathway, contributing to the
regulation of both homeodomain transcription factors,
which determine motor neuron subtype specification,
and bHLH factors, like the proneural factor neurogenin 2
(Ngn2), which drive neurogenesis. Oligodendrocyte pro-
duction requires the ongoing activity of Olig2 and is pre-
ceded by downregulation of Ngn2, a determinant of the
neuron-glial switch [7]. While oligodendrocytes retain the
capacity to divide after leaving the neural progenitor
domain, neuronal progenitor cells exit the cell cycle prior
to initiating migration and differentiation in the mantle
layer. Cell cycle exit represents part of the proneural activ-
ity of Ngn2 [3,4,8-10].
The impact of the timing of cell cycle exit on neural cell
fate and the timing of neuronal differentiation remains
unclear. Data indicate that cell cycle exit alone is insuffi-
cient to trigger neuronal differentiation [11,12]. Con-
versely, the onset of neuronal differentiation may be
hindered by forcing neural progenitor cells to cycle [13].
D-type cyclins (CyclinDs) are known to govern progres-
sion in G1, and forced expression of CyclinDs at early
stages of spinal cord development keeps neural progenitor
cells proliferating, impeding neuronal differentiation
[13]. In the hindbrain of jumonji (jmj) mutant mice, fail-
ure to turn off CyclinD1 alters the timing of neuronal dif-
ferentiation. Although the cells migrate into the
differentiating field, they retain neural progenitor traits,
including the ability to divide. This phenotype is rescued
by crossing the jmj mutant with CyclinD1 knockout mice
[14]. Reports also exist in the literature of neuronal cells
re-entering the cell cycle after migration and/or initiation
of neuronal differentiation [10,15-17]. For example, in
the developing spinal cord the cyclin-kinase inhibitor
(CKI) p57kip2 is expressed transiently in the nuclei of
nascent interneurons. In the absence of p57kip2, many
interneurons re-enter the cell cycle inappropriately for at
least one additional round of cell division but later exit to
begin differentiation [10]. The authors proposed a
requirement of the Cip/Kip subfamily of CKIs in timing
neuronal cell cycle exit but not differentiation. To date,
p27kip1 is the only CKI whose expression is described to
be both initiated and maintained in the nuclei of nascent
motor neurons; however, genetic disruption of p27kip1
causes no detectable neurogenic defect in the spinal cord
[10]. Thus, the influence of the timing of cell cycle exit on
motor neuron production remains difficult to determine.
To establish more clearly the importance of the temporal
regulation of cell cycle exit on cell-fate choice, we wished
to test the effect of forced cycling on the specification and
timing of differentiation. To this end, we tested the fate of
pMNs, which temporally result in two distinct cell types,
motor neurons and oligodendrocytes, following the
forced expression of CyclinD. We show that forcing pMNs
to cycle does not alter the production of motor neurons
but, rather, results in transgenic cells migrating to the dif-
ferentiating field and differentiating whilst cycling. This
leads to the generation of differentiated motor neurons
that incorporate bromodeoxyuridine (BrdU) and express
mitotic markers. Our findings demonstrate that retaining
cells in the cell cycle is not sufficient to maintain a reser-
voir of undifferentiated neural progenitor cells, with the
cycling cells instead proceeding with their programmed
specification and differentiation, regardless of cell cycle
exit.
Results
Long-term forced expression of CyclinD leads to the 
presence of proliferating cells in the differentiating field
We previously showed that forced expression of CyclinD1
or D2 for 24 hours in the neural tube favors the prolifera-
tion of transgenic neural progenitor cells at the expense of
neuronal differentiation [13]. These results suggest that
maintaining neural progenitor cells in proliferation is a
means of keeping them undifferentiated in the ventricular
zone.
To investigate this further, we analyzed the behavior of
neural progenitor cells overexpressing CyclinD1 or
CyclinD2 for longer periods of time to determine whether
these cells remain as undifferentiated progenitors.
CyclinD1-internal ribosomal entry site (IRES)-green fluo-
rescent protein (GFP), CyclinD2-IRES-GFP or control
IRES-GFP expression constructs were transfected by in ovo
electroporation on the left side of the neural tube of 1.5-
day-old chicken embryos [13]. The effects of CyclinD1 or
D2 forced expression were analyzed at 48 hours after elec-
troporation, that is, in 3- to 3.5-day-old spinal cord corre-
sponding to a peak in motor neuron production. Cross-
sections through the spinal cord of wild-type 3- to 3.5-day-Neural Development 2008, 3:4 http://www.neuraldevelopment.com/content/3/1/4
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old embryos showed that CyclinD1  and  D2  transcripts
were still expressed in the ventricular zone, the pMN
domain specifically expressing CyclinD1 (Figure 1). Cross-
sections of the CyclinD-electroporated spinal cord dis-
played GFP positive cells (GFP+) located in the mantle
zone (Figure 2) that were still expressing CyclinD, as con-
firmed by means of a tagged version of CyclinD2 (pCIG-
CyclinD2V5-IRES-GFP) (Figure 2a,b). This demonstrates
that forced expression of CyclinD1 or D2 does not alter
migration of the transgenic cells to the differentiating field.
To ascertain whether CyclinD transgenic cells located in
the mantle layer were still cycling, we performed a
30 minute pulse of BrdU just before fixation of the
embryos to detect cells in S phase, and immunostaining
using phospho-histone 3 antibody (P-H3) to detect
mitotic cells. In the wild-type spinal cord, or in embryos
electroporated with a control vector (data not shown),
cells in S phase were restricted to the ventricular zone and
mitotic cells confined along the lumen of the neural tube
(Figure 2c–g, right side). In the spinal cord of embryos
D-type cyclins display discrete domains of expression in the developing spinal cord Figure 1
D-type cyclins display discrete domains of expression in the developing spinal cord.(a,b) In situ analysis of CyclinD1 
(a) and D2 (b) expression on cross-sections of the neural tube of 3- to 3.5-day-old chicken neural tube. (c,d) Co-detection of 
the transcripts CyclinD1 or D2 (dark blue) with the protein Nkx2.2 (brown). (e-h) In situ hybridization performed on serial 
sections showing CyclinD1 (e), Olig2 in combination with anti-BrdU immunostaining (f), CyclinD2 (g), and Irx3 (h). Note that 
both CyclinD1 and D2 are present in the dorsal aspect of the ventricular zone (a,b). A small dorsal domain expresses CyclinD1 
at a lower level (a, asterisk). In the ventral part of the spinal cord, distinct domains (1, 2, 3) of ventral progenitors express dis-
tinct CyclinDs, the pMN domain expressing mainly CyclinD1. Transcripts encoding CyclinD1 seem more homogenously dis-
tributed along the apico-basal axis than those encoding CyclinD2, which are reinforced on the basal side (b).
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Transgenic cells overexpressing CyclinD migrate into the differentiating field while remaining in the cell cycle Figure 2
Transgenic cells overexpressing CyclinD migrate into the differentiating field while remaining in the cell 
cycle.(a,b) Forty-eight hours following forced expression of a tagged-CyclinD2 version, cells expressing GFP (green) and the 
transgenic protein detected with an anti-Tag-V5 antibody (blue) are observed in the ventricular zone and differentiating field. 
(c,d) Detection of the cells in S phase visualized following a 30 minute pulse of BrdU (red). (e-i) Detection of the phospho-his-
tone H3 (P-H3) on a cross-section of the spinal cord 48 h after overexpression of CyclinD2 (e,f, red) or D1 (g-i, blue). (h,i) 
Magnifications of the cell in anaphase shown in (g) (arrowhead). (a-f) Maximum projections of eight optical sections acquired at 
5 μm Z steps; (g-i) single optical sections.
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electroporated with CyclinD1 (n = 5/5 embryos) or
CyclinD2 (n = 1/1 embryo), we observed numerous GFP+
cells in S phase outside the ventricular zone (Figure 2d).
This was not observed in embryos electroporated with a
pCIG-IRES-GFP control vector (n = 0/5 embryos; data not
shown). We also clearly detected ectopic P-H3 positive
transgenic cells located in the differentiating field of
embryos electroporated with CyclinD1 or D2 (n = 9/9
with CyclinD1 and 10/10 with CyclinD2; Figure 2e–i) but
not in transgenic embryos electroporated with a pCIG
control vector (n = 0/9 embryos; data not shown). We
observed cells in anaphase/telophase among the ectopic
P-H3 positive cells, suggesting a progression through met-
aphase (Figure 2h,i). These observations show that neural
progenitor cells overexpressing CyclinD can migrate out
of the ventricular zone despite being in the cell cycle.
Hence, cell cycle exit is not a prerequisite for neural
progenitor cell migration.
Cycling neural progenitor cells in the mantle layer do not 
express markers of the ventricular zone
In the developing spinal cord, proliferating neural pro-
genitor cells restricted to the ventricular zone express a
specific panel of transcription factors, such as Sox2
throughout the entire zone and Olig2, Pax6 and Pax7 in
discrete domains along the ventral to dorsal axis [1].
Expression of these proteins is switched off once cells
migrate out of the ventricular zone and differentiate. Fol-
lowing our observations of transgenic cells overexpressing
CyclinD1 or D2 proliferating in the mantle layer, we
wanted to test whether these cells retain the expression of
proteins normally restricted to the ventricular zone,
namely Sox2, Olig2, Pax6 and Pax7. For each of these pro-
tein markers, we examined 400 transgenic cells located in
the mantle layer. As shown in Figure 3, we detected no
markers of the ventricular zone in cells overexpressing
CyclinD1 in the mantle layer. These data show that trans-
genic cycling cells in the differentiating field do not retain
the markers found in neural progenitor cells.
Cycling cells progress normally in their program of 
specification
Numerous changes occur at the gene expression level of
neural progenitor cells committed to becoming post-
mitotic neurons, including the onset of a program of spec-
ification. The well described sequence of activation of
transcription factors involved in motor neuron specifica-
tion includes an upregulation of MNR2 in committed
motor neuron progenitors during their ultimate division
and of Islet1 in post-mitotic differentiating motor neu-
rons (Figure 4). We observed that all the transgenic cells
located in the motor neuron columns and overexpressing
CyclinD1 or D2 were Islet1/2+. In accordance with this,
we identified the expression of MNR2 and Islet1/2 in
ectopic P-H3-expressing cells in the mantle layer
(Figure 4c–k). After a 30 minute pulse of BrdU, 32 ± 3.5%
(standard error of the mean (SEM); n = 24 optical sections
from 9 embryos electroporated with CyclinD1) of the
transgenic Islet1/2+ cells were in S phase (Figure 4l–q).
Such a proliferation rate is characteristic of a population
proliferating rapidly and asynchronously. These data sug-
gest that the sequence of activation of transcription factors
involved in motor neuron specification is not altered in
cycling pMNs.
Cycling cells progress through differentiation to axonal 
extension
The progression of neurogenesis also depends on the
ordered expression of transcription factors involved in
generic neuronal differentiation, initiated by the selection
of neural progenitor cells that upregulate the proneural
Ngn2. Scattered upregulation of Ngn2 occurred in trans-
genic cells overexpressing CyclinD1 located in the lateral
ventricular zone, similar to that seen on the control side
(Figure 5a–d). Similarly, as with the other markers of the
ventricular zone, Ngn2 was not detected in cells overex-
pressing CyclinD1 in the mantle layer. Instead, these cells
expressed the pan-neuronal marker HuC/HuD, with
transgenic cells expressing both P-H3 and HuC/HuD after
electroporation of CyclinD1 (data not shown) or D2 (Fig-
ure 5e–g). As a complementary marker, we used the BEN/
SC1/DM-GRASP antibody to recognize a membrane glyc-
oprotein of the immunoglobulin superfamily on motor
and sensory neurons as well as floor plate cells [18]. BEN/
SC1/DM-GRASP is at first detected on the motor neurons
at the level of the cell body just after withdrawal from the
cell cycle and soon afterwards its location extends to the
elongating axon. As illustrated in Figure 5h–k, after 48 h
of CyclinD1-forced expression, we clearly observed trans-
genic mitotic cells expressing BEN/SC1/DM-GRASP at the
level of the cell body. These observations further demon-
strate the ability of transgenic cells to differentiate whilst
remaining in the cell cycle.
To determine whether these cycling and differentiating
motor neurons were able to extend axons, a CyclinD1-
IRES-eGFP expression construct was created, enhanced
GFP (eGFP) having previously been used successfully to
follow axonal tracts [19]. This new construct resulted in a
similar phenotype to that described with the CyclinD1-
IRES-GFP construct (data not shown). We analyzed
embryos 72 h after electroporation, a stage when axons
are well developed. Figure 6a,c shows numerous eGFP+
axons exiting out of the spinal cord via the ventral root
and projecting along nerve branches supplying the body
wall and limb bud. Combining eGFP detection with BEN/
SC1/DM-GRASP showed that these transgenic axons,
emanating from the ventral root, originate from motor
neurons (Figure 6a–d). Some of these transgenic cells
extending BEN/SC1/DM-GRASP-positive axons alsoNeural Development 2008, 3:4 http://www.neuraldevelopment.com/content/3/1/4
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Analysis of transcription factors restricted to neural progenitor cell domains in transgenic cells overexpressing CyclinD Figure 3
Analysis of transcription factors restricted to neural progenitor cell domains in transgenic cells overexpressing 
CyclinD. Immunodetection of (a-d) Sox2, (e-h) Olig2, (i-l) Pax6, and (m-p) Pax7, showing that transgenic cells (green) co-
express markers of the ventricular zone (yellow cells) only when located within that zone. For each marker, a total of at least 
400 transgenic cells were analyzed from 5 independent 40 μm sections from 4 transgenic embryos. Each image represents the 
maximum projections of 8 optical sections acquired at 5 μm Z steps. (c,d,g,h,k,l,o,p) High magnifications of the zones framed by 
dashed lines on the adjacent sections.
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Motor neurons progress in their program of specification while remaining in the cell cycle Figure 4
Motor neurons progress in their program of specification while remaining in the cell cycle.(a-k) Co-immunode-
tection of Islet1/2 (a-i, green) or MNR2 (j,k, green) with P-H3 (red). (a,b) Maximum projections; the electroporated side is on 
the left. (c) Single optical section showing a high magnification view at the level of the cell marked with an arrow in (a,b). (d-g) 
Orthogonal sections along the cell marked with an arrow in (c). (h-k) Single optical sections taken with a 63× objective. Dotted 
lines mark the limit of the mitotic transgenic cell. (l-q) Co-immunodetection of BrdU (red) and Islet1/2 (green). All the pic-
tures are single optical sections. (n-q) Orthogonal projections along the cell marked with an arrow in (m).
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Cell cycle exit is not required for initiation or progression of neuronal differentiation Figure 5
Cell cycle exit is not required for initiation or progression of neuronal differentiation.(a-d) Immunodetection of 
Ngn2 (red) after 48 h of CyclinD1 forced expression. The transgenic cells located in the motor neuron differentiating field do 
not retain Ngn2 expression. (a-d) maximum projections; (c,d) high magnifications of the zone in the dotted lines in (a) and (b), 
respectively. The arrow marks a transgenic cell expressing Ngn2. (e-g) Single optical sections showing the co-expression of 
HuC/D (green) and P-H3 (red) in the ventral horn of a spinal cord 48 h after electroporation with a CyclinD2 expression 
vector. (h-k) Co-immunodetection of BEN/SC1/DM-GRASP (green) and P-H3 (red) 48 h after electroporation with CyclinD1. 
(h-k) Single optical sections. (i-k) High magnifications of the cell marked with an arrow in (h); the GFP channel is off. (j,k) 
Orthogonal sections along the mitotic cell.
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Effects of 72 h of sustained expression of CyclinD on motor neuron differentiation Figure 6
Effects of 72 h of sustained expression of CyclinD on motor neuron differentiation.(a-d) Transverse sections 
through the spinal cord at the brachial level showing the axonal tracts. eGFP+ axons are found in motor nerves, in the ventral 
commissure and in the sensory nerves, that is, corresponding to the tracts originating from the different locations where trans-
genic cells are detected. Immunodetection of BEN/SC1/DM-GRASP (red) reveals an enlarged ventral root on the electropo-
rated side compared to the contralateral control side (underlined with dashed lines in (d)). (a,d) Images obtained with an 
epifluorescent microscope. (e,f) Co-immunodetection of BEN/SC1/DM-GRASP (red) and P-H3 (blue) 72 h after electropora-
tion with CyclinD1 reveals the presence of mitotic cells displaying an axon. (e-f) Single optical sections; (f) high magnification of 
the cell marked with an arrow in (e) – the GFP channel is off. (g,h) Single optical sections showing eGFP and Islet1/2 (red) 72 
h after CyclinD1 electroporation. The population of motor neurons is increased on the transgenic side. (i,j) Single optical sec-
tions showing eGFP, Islet1/2 (red) and BrdU (blue). (j) A high magnification of (i). (k,l) Seventy-two hours following forced 
expression of a tagged version of CyclinD2, cells expressing GFP (green) still express CyclinD2 visualized with an anti-Tag-V5 
antibody (red). The TagV5 is clearly detected in the differentiating field. (k,l) Maximal projections.
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expressed the mitotic marker P-H3, confirming the axon-
growing ability of a neuron even though in mitosis
(Figure 6e,f). As electroporation allows only the transient
expression of transgenes, we were unable to determine
whether these motor neurons exhibit synaptic differentia-
tion at more mature stages.
Together, these data show the ability of spinal progenitor
cells to migrate, differentiate and extend axons independ-
ently of their cell cycle exit, arguing strongly against cell
cycle exit representing a gate for neuronal differentiation.
Sustained expression of CyclinD1 leads to an increase in 
the motor neuron population
Whilst we observed no apparent change concerning the
size of motor neuron columns after 48 h of forced
CyclinD1 or D2 expression (Figure 4b–l), the spinal ven-
tral root was larger on the transgenic side compared to the
contralateral control side after 72 h of forced CyclinD1
expression (Figure 6b,d). We quantified the spinal ventral
root by measuring the span of the ventral root at the
emerging point on each side and determining the ratio of
the transgenic side/control side (Figure 6d, dashed lines).
We measured an increase in this ratio following forced
expression of CyclinD1 compared to that found in
embryos electroporated with a control vector; 1.6 ± 0.31
(n = 7 sections from 3 embryos) compared to 0.99 ± 0.17
(n = 4 sections), respectively. This observation suggests an
increase in the number of motor neurons extending axons
in the ventral horn following 72 h of CyclinD forced
expression. To determine any augmentation in the motor
neuron population, we quantified and compared the
number of Islet1/2-positive cells on the control side ver-
sus the CyclinD1 electroporated side (Figure 6g,h). The
ratio of Islet1/2+ cells on the transgenic side versus the
control side was 1.59 ± 0.03 (SEM, n = 42 optical sections
from 3 embryos). These data confirm an increase in the
number of differentiating motor neurons following 72 h
of CyclinD1 forced expression and suggest that cycling
and differentiating motor neurons augment the neuronal
population.
Further analysis of the GFP+ cells located in the Islet1/2+
domain revealed that all the transgenic cells co-expressed
the pan-motor neuron marker Islet1/2. Moreover, Lim1/
2, a widely expressed marker of interneurons, remained
excluded from the transgenic population located in the
motor neuron columns (data not shown). These observa-
tions suggest that the dividing cells located in the ventral
horn gave rise to motor neurons.
Sustained expression of CyclinD allows only a limited 
number of divisions in the motor neuron population
We next wondered whether forced expression of CyclinD1
would cause differentiating motor neurons to keep cycling
for a number of divisions or if the effect was transient. To
gain insight into this we determined the proliferation rate
in the GFP+/Islet1/2+ cells after 72 h of forced CyclinD1
expression (Figure 6i,j) and compared it to that observed
at 48 h (Figure 4l,m). After a 30 minute pulse of BrdU,
only 11% ± 1.21 (SEM, n = 19 optical sections from 3
embryos) of transgenic cells incorporated BrdU (versus
32% ± 3.5 at 48 h), indicating a rapid decrease in the pro-
liferation rate in the differentiating motor neurons. One
feasible explanation for this could be the loss of trans-
genic CyclinD from these differentiating motor neurons;
however, the use of the tagged version of CyclinD2 clearly
demonstrated a remaining considerable co-expression of
the transgene with the GFP, thereby arguing against such
a possibility (Figure 6k,l).
Another explanation for the decrease may be that the pro-
liferating cells undergo apoptosis, thus explaining the
rapid loss of the proliferating population. To investigate
this possibility, we determined the level of an active form
of caspase 3 in the spinal cord at 72 h or 96 h post electro-
poration of CyclinD1. We detected no significant differ-
ence in caspase 3 levels (data not shown), suggesting that
differentiating motor neurons perform only a limited
number of divisions despite the maintenance of CyclinD.
Influence of neuroepithelium age on the behavior of 
neural progenitor cells
We previously observed that overexpressing CyclinD for
24 h in the neural tube of 1.5-day-old embryos impedes
neuronal differentiation while a further 24 h (total 48 h)
leads to differentiating and cycling cells. Two hypotheses
can be proposed: the critical factor is either the length of
CyclinD overexpression (24 h versus 48 h) or the age of
the neuroepithelium (E2.5 and E3.5, respectively, at the
time of analyses). To discriminate between these hypoth-
eses, we electroporated the neural tube of 1.5- and 2.5-
day-old embryos and evaluated the phenotype by quanti-
fying the number of transgenic sections displaying ectopic
P-H3 staining in the mantle layer 24 h and 48 h following
overexpression at E1.5 and 24 h after overexpression at
E2.5; the data are illustrated in Figure 7. At 48 h after elec-
troporation at E1.5, 100% of the sections displayed an
identical phenotype to that obtained at 24 h following
electroporation at E2.5 (97%). Conversely, only half of
the sections displayed this phenotype 24 h after electropo-
ration at E1.5 (53%). The same evaluation of the pheno-
type performed 72 h after electroporation at E1.5 revealed
81% of the sections still displaying P-H3 positive
cells. These data point more to an influence of age of the
neural tube than to the length of CyclinD forced expres-
sion on the phenotype, and that the most penetrant phe-
notype is indeed observed at the peak of motor neuron
production (E3.5).Neural Development 2008, 3:4 http://www.neuraldevelopment.com/content/3/1/4
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Discussion
Cell cycle and neurogenesis
One intriguing observation we made is the domain-
specific expression of CyclinD1 and D2 in the chicken
neural tube. The pMNs express mostly CyclinD1, suggest-
ing that this cell cycle regulator might play a critical
role in the maintenance of this particular progenitor
domain. Concordantly, a recent study reported that the
pMNs of Xenopus  embryos also specifically express one
CyclinD, related to CyclinD1, and that inhibition of this
CyclinD results in the specific loss of the pMNs [20].
In our gain-of-function experiments, CyclinD1 and
CyclinD2 behaved identically in their ability to maintain
transgenic cells in the cell cycle even during differentia-
tion. This suggests some redundancy in their function;
however, our strategy did not allow us to ascertain their
possible subtle functional differences. Such differences
have recently been reported in the embryonic brain with
CyclinD1 and CyclinD2 defining separate progenitor
pools [21,22]. Comparative analysis of cell cycle regula-
tion in D1- and D2-null mice suggests that compared to
Influence of the maturity of the neural tube on phenotype occurrence Figure 7
Influence of the maturity of the neural tube on phenotype occurrence.(a) Schematic representation showing the age 
of the embryo at the time of electroporation and the different times after electroporation at which the embryos were fixed to 
evaluate the phenotype. For each experimental condition, 23 to 48 sections from 2 to 3 electroporated embryos were ana-
lyzed and the percentage of sections displaying ectopic P-H3 cells on the transgenic side determined. The corresponding values 
are reported for each experimental condition. (b-d) Cross-sections of the spinal cord showing the phenotype 24 h after elec-
troporation at E1.5 (b,c) and E2.5 (d), respectively. Tuj1 (b) marks the differentiating neurons. The arrows in (c,d) mark mitotic 
cells in ectopic positions. (b-d) Images obtained with an epifluorescent microscope.
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CyclinD1, CyclinD2 exerts a stronger inhibitory influence
on p27 to delay the cell cycle exit of progenitors [22].
One important characteristic that applies to all mature
neurons is that they never divide. Nevertheless, data have
accumulated showing that young neurons undergo extra
divisions when CKIs are removed [10,17]. These mole-
cules are known to enforce permanent cell cycle exit upon
terminal differentiation. In mice lacking the CKIs p19/
Ink4d and p27/kip1, neurons divide after migration to
their final position in the brain [17]. In the absence of
p57Kip2, many spinal interneurons re-enter the cell cycle
for at least one additional round of cell division before
ultimately differentiating [10]. Indeed, p57Kip2 has been
shown to arrest cell cycle progression at G1 by antagoniz-
ing CyclinD1, probably among other activities. As yet,
p27 is the only CKI found to be expressed in young post-
mitotic motor neurons, although p27-/- embryos have no
detectable neurogenic defect [10]. One remaining open
question is whether cell cycle exit is a prerequisite for
motor neuron differentiation. Here we have shown that,
as with interneurons, motor neurons can migrate into the
differentiating field and differentiate without exiting the
cell cycle. This phenotype culminates at the peak of neu-
ronal production and results in an increase in the number
of motor neurons, as is observed for interneurons. More-
over, our results demonstrate the ability of neurons to
upregulate a program of transcription factors associated
with early differentiation and extend axons while cycling.
Controlling cell cycle exit in pMNs
This now leads on to questions surrounding the possible
mechanism controlling the cell cycle exit for motor neu-
rons. Although p27 seems dispensable for cell cycle exit in
motor neurons, other molecules besides those of the CKI
family could be involved in controlling cell cycle exit for
this particular neuronal population. A recent study per-
formed in Drosophila proposed that both the retinoblast-
oma and p27 homologs contribute to parallel repression
of E2F and Cyclin/Cdk activity, respectively, in differenti-
ating neurons [23]. Interestingly, in mouse embryos in
which the retinoblastoma protein is inactivated, many
ectopically dividing cells are found in the central and
peripheral nervous system, including the ventral horns of
the spinal cord where motor neurons differentiate
[15,16]. This suggests that the retinoblastoma protein
(pRB) may also play an important repressive role in motor
neuron differentiation-associated cell cycle exit. One rea-
sonable hypothesis is that overexpression of CyclinD in
the neural tube gives rise to ectopic mitosis, in part by
maintaining pRB in an inactive hyperphosphorylated
state, thus phenocopying the phenotype of pRB loss-of-
function.
Forcing neural progenitor cells to cycle is not sufficient to 
alter cell-fate choice
We have shown that keeping a neural progenitor cycling is
not sufficient to maintain them in an undifferentiated
state in reserve for later born cell types. Indeed, forced pro-
liferation of the progenitors of the pMN domain, which
first produce motor neurons and, later on, oligodendro-
cytes, did not abolish motor neuron production but
instead gave rise to cycling differentiating motor neurons.
Furthermore, we detected no change at the onset of oli-
godendrocyte production (data not shown). One unan-
swered question concerns the fate of the daughter cells of
the dividing motor neurons. While only a clonal analysis
experiment may answer this question accurately, certain
observations suggest that they give rise to two motor neu-
rons: firstly, they are unlikely to die rapidly after division
since we detected no increase in cell death in the trans-
genic population; secondly, 72 h following electropora-
tion, the number of differentiating motor neurons was
found to be higher in the population containing dividing
transgenic cells when compared to the contralateral con-
trol side, with all the transgenic cells expressing the pan-
motor neuron marker Islet1/2. It could be argued that the
increase in the number of differentiating motor neurons is
the consequence of an increase in the population of pMNs
in transgenic embryos. However, the size of the Olig2+
progenitor domain showed no significant increase follow-
ing forced expression of CyclinD1, suggesting that the rise
in motor neuron population is rather the consequence of
dividing differentiating motor neurons than an increase in
the progenitor population. Nevertheless, we cannot
exclude that the increase in the differentiating motor neu-
ron population occurs, at least in part, as a consequence
of an increased production of neural progenitor cells that
rapidly migrate into the differentiating field and initiate
their differentiation without exiting the cell cycle.
Controlling the timing of neuronal differentiation
Our data argue against cell cycle exit being the gateway in
the timing of motor neuron differentiation; however; it is
still possible that other cell cycle parameters influence this
timing event. Contrary to what has been reported for cor-
tical development [24], the orientation of cell division
does not seem to be a critical factor in timing neurogene-
sis in the spinal cord [25-28]. One promising possibility is
the effect of varying cell cycle kinetics, including the dura-
tion and length of the gap phases, which have been shown
to influence the switching of neural progenitors from
proliferative to neuron-generating divisions in the retina
and brain [29-32]. Concordantly, in the chicken
neural tube, fibroblast growth factor-mediated inhibition
of neuronal differentiation is associated with cell cycle
acceleration [28].Neural Development 2008, 3:4 http://www.neuraldevelopment.com/content/3/1/4
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In our experimental context, we observed cycling differen-
tiated neurons in the mantle layer. Examples of cells
retaining neural progenitor characteristics found in the
mantle layer have also been described previously. Jmj is a
direct transcriptional repressor of CyclinD1 and ectopic
proliferating cells are present in the mantle layer in the
hindbrain of jmj mutant mice [14]. Moreover, crossing jmj
mutants with mice in which CyclinD1 function has been
removed is sufficient to rescue the phenotype. According
to our observations, we would expect that the cycling cells
in the mantle layer of jmj mutants are differentiating neu-
rons. On the contrary, the ectopic cycling cells in jmj
mutants were shown to retain markers of the ventricular
zone without expressing markers of differentiation [14].
The easiest interpretation of this apparent paradox is a dif-
ference in the behavior of neural progenitor cells in the
hindbrain compared to the spinal cord, in agreement with
the absence of ectopic proliferating cells in the spinal cord
of the jmj  mutant. The presence of proliferating cells
retaining traits of neural progenitors, including Sox2
expression, in the spinal mantle layer has been reported
following inhibition of the G-protein regulator LNG [27].
LNG regulates mitotic spindle movements to favor planar
division, giving rise to two progenitor cells. Inhibition of
LNG activity leads to random spindle orientation, result-
ing in the neural progenitor cells leaving the ventricular
zone prematurely though retaining neural progenitor
characteristics whilst in the differentiating field. This sug-
gests that these cells do not actually reach the maturation
state enabling them to differentiate further in the mantle
layer. Hence, in addition to cell cycle exit, the maturation
state of the neural progenitor cells would influence the
timing of neuronal differentiation. In accordance with
this, we observed that while forced expression of CyclinD
in the young neural tube promotes progenitor cell prolif-
eration at the expense of neuronal differentiation [13],
this phenotype is transient and neural progenitor cells
soon afterwards migrate into the mantle layer and differ-
entiate, regardless of their proliferation status. What
changes occur between a young and more mature neural
tube to explain such a difference? One of the major differ-
ences occurring during the maturation of the neuroepithe-
lium is the setting-up of combinations of homeodomain
proteins into discrete progenitor cell domains [1]. Neural
progenitor cells of a particular domain are then destined
to give rise to a particular subtype of neurons. Further-
more, these patterning genes not only direct cell identity
but also play a key role in controlling the timing of neuro-
nal differentiation. Thus, in the pMN, Olig2 upregulates
the bHLH factor Ngn2, and the ratio Olig2/Ngn2 controls
motor neuron differentiation [3,4,6]. Pax6 also pushes
neural progenitor cells towards neuronal commitment via
Ngn2 upregulation [33-36], with the switching off of Pax6
being required for the initiation of neuronal differentia-
tion [33]. Our data show that in cells overexpressing
CyclinD, upregulation of Ngn2 takes place and the tem-
poral switching off of Olig2 and Pax6 occurs as commit-
ted neurons leave the ventricular zone, leading to the
differentiation of the neurons regardless of cell cycle exit.
Together, these data strongly suggest that while cell cycle
exit is not necessary for differentiation, the switching off
of patterning genes is a determining event in the control
of the timing of neuronal differentiation, at least in the
spinal cord.
Conclusion
The present study, using the pMN as a model, demon-
strates that forcing a neural progenitor cell to cycle is not
sufficient to keep it undifferentiated in the spinal cord.
Instead, the neural progenitor cells were shown to differ-
entiate into neurons and project axons into the right path-
ways, regardless of cell cycle exit. We propose that once
the combinatorial expression of homeodomain proteins
is set-up in a spinal progenitor domain, this program is
robust enough to promote the activation of the transcrip-
tional sequence involved in the specification and differen-
tiation of neurons independently of cell cycle exit.
Therefore, cell cycle exit seems not to be a prerequisite to
neuronal differentiation in the formation of post-mitotic
neurons; rather, both events are coordinated during nor-
mal neurogenesis.
Materials and methods
Embryos
Fertile hens' eggs, obtained from a local supplier, were
incubated at 38°C in a humidified incubator to yield
embryos of appropriate stages [37].
DNA constructs and in ovo electroporation
In ovo electroporation experiments were performed using
pCIG-CyclinD1-IRES-GFP or pCIG-CyclinD2-IRES-GFP
constructs as already described [13]. To visualize the
axons of transgenic cells, the nuclear GFP from the pCIG-
CyclinD1-IRES-GFP was replaced by eGFP. Chicken
CyclinD2 was cloned into the pTracer-EF (Invitrogen,
Carlsbad, CA, USA) containing a V5 tag and the tagged
cDNA subcloned into pCIG [38]. Vectors were electropo-
rated as previously described [13].
In situ hybridization and immunohistochemistry
Detection of transcripts and proteins were performed on
40 μm vibratome sections as previously described [13].
The antibodies used in the present studies were: anti-
Nkx2.2, anti-Pax7, anti-BrdU, anti-Islet1/2, anti-MNR2,
anti-Lim1/2 and anti-BEN/SC1/DM-GRASP (Hybridoma
Bank), anti-Sox2 (a gift from Dr T Edlund), anti-P-H3
(Upstate Biotechnology, Lake Placid, NY, USA), O4
antibody (a gift from Dr R Bansal), anti-HuC/D (Molecu-
lar Probes, Eugene, OR, USA), anti-GFP (Torrey Pines
Biolabs, Houston, TX, USA), anti-Olig2 (Chemicon,Neural Development 2008, 3:4 http://www.neuraldevelopment.com/content/3/1/4
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Billerica, MA, USA), anti-active caspase-3 (BD PharMin-
gen, Franklin Lakes, NJ, USA), anti-Pax6 (BAbCO, Rich-
mond, CA, USA), anti-Ngn2 (a gift from D Anderson [5]),
anti-neuronal class III β-tubulin (Tuj1, BAbCO), and anti-
V5 (Invitrogen).
Cell proliferation analysis
Cell proliferation was evaluated by BrdU incorporation
(BrdU labeling and detection kit I, Roche, Basel, Switzer-
land). BrdU (10 mM) was injected into the lumen of the
neural tube and the embryos harvested 30 minutes later.
BrdU immunodetection was performed on vibratome sec-
tions as previously described [13].
Analysis and imaging of the data
Sections of 40 μm were analyzed using an epifluorescent
Nikon microscope or a SP2 Leica confocal microscope.
Confocal analyses of the 40 μm vibratome sections were
performed on sections acquired at 5 μm Z steps. The data
are presented as the maximum projection of optical sec-
tions or as single optical sections, as mentioned in the
figure legends.
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